Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

5 structures for P15907

Entry ID Method Resolution Chain Position Source
4JS1 X-ray 209 A A 89-406 PDB
4JS2 X-ray 230 A A 89-406 PDB
6QVS X-ray 160 A A/B 132-406 PDB
6QVT X-ray 170 A A/B 132-406 PDB
AF-P15907-F1 Predicted AlphaFoldDB

293 variants for P15907

Variant ID(s) Position Change Description Diseaes Association Provenance
rs754480789
CA89906366
4 T>I No ClinGen
ExAC
gnomAD
CA2748067
rs754480789
4 T>N No ClinGen
ExAC
gnomAD
rs1336912082
CA355846958
5 N>H No ClinGen
gnomAD
CA355846962
rs1483350433
5 N>S No ClinGen
gnomAD
CA2748068
rs781047841
6 L>P No ClinGen
ExAC
gnomAD
rs1579351552
CA355846974
7 K>R No ClinGen
Ensembl
CA2748069
rs747797139
8 K>E No ClinGen
ExAC
gnomAD
CA355846981
rs1560173325
8 K>R No ClinGen
Ensembl
CA355846998
rs1173064800
10 F>C No ClinGen
TOPMed
TCGA novel 12 C>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770801889
CA355847025
14 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs770801889
CA2748073
14 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs770801889
CA89906367
14 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA355847030
rs1173327620
15 L>V No ClinGen
gnomAD
CA2748074
rs774309227
16 V>F No ClinGen
ExAC
gnomAD
TCGA novel 18 L>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1460870059
CA355847049
18 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA2748075
rs747110392
21 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs776908493
CA2748077
23 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1435899723
CA355847081
23 I>T No ClinGen
TOPMed
gnomAD
rs538219161
CA2748076
23 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1367190687
CA355847083
24 C>R No ClinGen
gnomAD
rs372532525
CA2748078
24 C>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2748079
rs765387130
25 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs765387130
CA89906369
25 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 28 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA355847133
rs1333293311
30 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA355847130
rs1312535523
30 K>R No ClinGen
gnomAD
CA355847146
rs1211853675
32 G>A No ClinGen
gnomAD
rs1560173399
CA355847144
32 G>R No ClinGen
Ensembl
CA548799922
rs1258582790
34 Y>* No ClinGen
gnomAD
rs905099697
CA89906370
35 Y>N No ClinGen
TOPMed
CA355847166
rs1208739712
35 Y>S No ClinGen
gnomAD
rs1446756819
CA355847171
36 D>N No ClinGen
TOPMed
rs1250447742
CA355847186
38 F>L No ClinGen
gnomAD
CA89906371
rs1003490678
39 K>I No ClinGen
TOPMed
rs1453072162
CA355847199
39 K>N No ClinGen
gnomAD
TCGA novel 39 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1193426631
CA355847207
41 Q>K No ClinGen
gnomAD
rs376769275
CA2748082
43 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA355847252
rs1468378068
46 Q>H No ClinGen
TOPMed
CA89906372
rs1034480430
46 Q>R No ClinGen
Ensembl
rs1230779156
CA355847272
49 K>N No ClinGen
TOPMed
rs766835893
CA2748084
50 S>I No ClinGen
ExAC
gnomAD
CA355847282
rs1322593876
51 L>V No ClinGen
gnomAD
rs752093218
CA2748085
54 L>S No ClinGen
ExAC
gnomAD
rs373712458
CA2748086
55 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2748088
rs752196419
56 M>T No ClinGen
ExAC
gnomAD
CA2748087
rs767139133
56 M>V No ClinGen
ExAC
gnomAD
CA2748089
rs755850692
57 G>R No ClinGen
ExAC
gnomAD
TCGA novel 58 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs142344871
CA2748090
58 S>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs749074261
CA2748091
60 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1269422200
CA355847354
62 S>Y No ClinGen
gnomAD
TCGA novel 63 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs983899606
CA89906374
64 S>F No ClinGen
TOPMed
rs757051175
CA2748092
66 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs1405425072
CA355847378
66 S>R No ClinGen
gnomAD
CA2748094
rs778777723
68 T>A No ClinGen
ExAC
gnomAD
CA2748095
rs771931718
68 T>I Variant assessed as Somatic; 4.621e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2748093
rs778777723
68 T>S No ClinGen
ExAC
gnomAD
rs748178562
CA2748097
70 D>G No ClinGen
ExAC
rs368632124
CA2748098
71 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs774730961
CA2748100
72 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs773452361
CA2748099
72 H>R No ClinGen
ExAC
gnomAD
rs1201863290
CA355847428
74 G>V No ClinGen
TOPMed
rs151284888
CA2748101
COSM1042391
75 R>C Variant assessed as Somatic; 4.623e-05 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs558830065
CA2748102
75 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA355847442
rs1164064322
77 T>A No ClinGen
gnomAD
rs140438545
CA2748103
78 L>F No ClinGen
ESP
ExAC
gnomAD
rs768086412
CA355847450
78 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs768086412
CA2748104
78 L>R No ClinGen
ExAC
TOPMed
gnomAD
rs1335084072
CA355847453
79 G>D No ClinGen
TOPMed
rs150410379
CA2748106
79 G>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA89906379
rs763884230
80 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA2748109
rs370846354
80 S>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2748108
rs370846354
80 S>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2748107
rs763884230
80 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA355847482
rs1322169974
84 L>P No ClinGen
TOPMed
gnomAD
rs778776277
CA355847479
84 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs750130755
CA2748111
86 K>E No ClinGen
ExAC
gnomAD
rs758356511
CA2748112
86 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs201339364
CA89906380
87 A>D No ClinGen
Ensembl
CA355847502
rs1323988775
88 K>E No ClinGen
TOPMed
gnomAD
rs1579352073
CA355847523
91 A>T No ClinGen
Ensembl
CA355847531
rs1232712342
92 S>F No ClinGen
gnomAD
CA89906381
rs200149315
92 S>P No ClinGen
gnomAD
CA355847536
rs1444990041
93 F>V No ClinGen
TOPMed
rs748266782
CA2748114
94 Q>R No ClinGen
ExAC
gnomAD
rs767740098
CA89906383
95 V>L No ClinGen
Ensembl
rs1260365970
CA355847560
96 W>* No ClinGen
TOPMed
TCGA novel 96 W>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA355847585
rs1474927008
99 D>E No ClinGen
gnomAD
rs1560173635
CA355847591
COSM1042393
100 S>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA355847611
rs1182448647
103 K>I No ClinGen
gnomAD
CA2748115
rs769842676
106 I>V No ClinGen
ExAC
gnomAD
CA355847637
rs1406972256
107 P>S No ClinGen
gnomAD
CA2748116
rs777923061
110 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 111 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA89906384
rs575421483
112 I>T No ClinGen
Ensembl
rs987759918
CA89906385
117 L>Q No ClinGen
TOPMed
rs935522265
CA89906387
118 S>I No ClinGen
TOPMed
CA89906388
rs770999685
119 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA2748118
rs770999685
119 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA89906390
rs946491486
122 Y>* No ClinGen
TOPMed
gnomAD
rs893553458
CA89906389
122 Y>F No ClinGen
TOPMed
CA2748119
rs774799258
123 K>R No ClinGen
ExAC
gnomAD
CA355847759
rs1324920923
124 V>A No ClinGen
TOPMed
rs1274545122
CA355847756
124 V>L No ClinGen
gnomAD
rs1274545122
CA355847755
124 V>M No ClinGen
gnomAD
CA2748121
rs772743022
127 K>R No ClinGen
ExAC
gnomAD
CA355847798
rs1239339370
130 G>A No ClinGen
gnomAD
rs1404750320
CA355847812
133 I>L No ClinGen
TOPMed
rs142229283
CA355847838
136 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs142229283
CA2748123
136 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs146159160
CA2748124
COSM1042394
137 A>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA355847846
rs1474195377
137 A>V No ClinGen
TOPMed
rs1036404925
CA89906394
139 A>S No ClinGen
gnomAD
CA355847855
rs1036404925
139 A>T No ClinGen
gnomAD
CA2748125
rs138824619
141 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs761543274
CA2748126
141 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA355847867
rs761543274
141 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs377510121
CA2748127
143 H>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2748130
rs149308342
145 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2748129
COSM3719366
rs527877833
145 R>W Variant assessed as Somatic; 0.0 impact. haematopoietic_and_lymphoid_tissue [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs1366467487
CA355847916
149 N>D No ClinGen
gnomAD
CA2748131
rs751485938
151 S>C No ClinGen
ExAC
gnomAD
rs754842583
CA2748132
153 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs968006280
CA89906399
157 D>G No ClinGen
TOPMed
gnomAD
rs771215054
CA89906398
157 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs771215054
CA2748135
157 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs771215054
CA355847968
157 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1435592154
CA355847987
160 F>L No ClinGen
TOPMed
CA2748136
rs778969734
161 N>S No ClinGen
ExAC
gnomAD
CA355847998
rs778969734
161 N>T No ClinGen
ExAC
gnomAD
rs746281001
CA2748137
162 T>A No ClinGen
ExAC
gnomAD
rs144486229
CA2748139
164 E>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2748140
rs747527436
165 W>R No ClinGen
ExAC
gnomAD
rs768988754
CA2748141
166 E>Q No ClinGen
ExAC
gnomAD
rs776230435
CA2748142
167 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1172858109
CA355848038
167 G>V No ClinGen
gnomAD
CA2748143
rs761190193
170 P>H No ClinGen
ExAC
gnomAD
CA89906401
rs935622576
170 P>S No ClinGen
TOPMed
CA355848064
rs1398454149
171 K>N No ClinGen
gnomAD
CA355848060
rs1579352449
171 K>R No ClinGen
Ensembl
CA2748144
rs764983228
172 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs200865084
CA2748145
173 S>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA355848079
rs1560173813
174 I>L No ClinGen
Ensembl
rs751297612
CA2748148
177 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA2748149
rs754929372
179 G>R No ClinGen
ExAC
gnomAD
rs753987883
CA2748151
180 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA89906402
rs1033386410
180 P>S No ClinGen
TOPMed
gnomAD
CA355848127
rs1247829228
COSM1227679
181 W>* large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
TCGA novel 183 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA355848142
rs1268900006
183 R>S No ClinGen
gnomAD
rs1227899080
CA355848136
183 R>W No ClinGen
gnomAD
CA355848145
rs1579352509
184 C>G No ClinGen
Ensembl
CA355848174
rs1331287018
188 S>L No ClinGen
TOPMed
gnomAD
rs746081323
CA2748154
192 S>F No ClinGen
ExAC
gnomAD
rs1320276116
CA355848214
195 S>Y No ClinGen
TOPMed
CA355848222
rs1471375432
196 S>F No ClinGen
gnomAD
CA355848225
rs1218753084
197 Q>* No ClinGen
TOPMed
rs747333324
CA2748157
199 G>S No ClinGen
ExAC
gnomAD
CA355848241
rs1368453583
200 R>G No ClinGen
TOPMed
TCGA novel 201 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769241343 202 I>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA355849175
rs748717915
203 D>E No ClinGen
gnomAD
CA89906406
rs200944757
203 D>N No ClinGen
TOPMed
CA355849181
rs1339877596
204 D>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA355849185
rs1452041754
204 D>V No ClinGen
TOPMed
CA2748181
rs777284898
205 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA2748183
rs770609191
207 A>S No ClinGen
ExAC
gnomAD
CA2748184
rs770609191
207 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA355849286
rs1423883787
212 N>D No ClinGen
gnomAD
rs1190289289
CA355849297
213 G>R No ClinGen
gnomAD
rs1169572938
CA355849392
220 Q>H No ClinGen
TOPMed
gnomAD
TCGA novel 221 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs775286088
CA2748187
222 D>H No ClinGen
ExAC
gnomAD
CA355849435
rs1464772600
223 V>A No ClinGen
gnomAD
TCGA novel 223 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1302448225
CA355849445
224 G>D No ClinGen
gnomAD
CA355849453
rs1403092268
225 T>A No ClinGen
gnomAD
rs928510292
CA89907290
225 T>R No ClinGen
Ensembl
rs938592708
CA89907291
227 T>A No ClinGen
Ensembl
TCGA novel 227 T>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760546808
CA2748188
227 T>N No ClinGen
ExAC
TOPMed
gnomAD
rs1314791158
CA355849490
228 T>I No ClinGen
gnomAD
CA355849511
rs1273664154
229 I>M No ClinGen
TOPMed
CA355849504
rs368367142
229 I>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2748189
rs368367142
229 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2748190
COSM1421543
rs750567016
230 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs763097294
CA2748191
230 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs139818568
CA89907293
231 L>V No ClinGen
ESP
TOPMed
gnomAD
CA355849559
rs1399980138
232 M>T No ClinGen
TOPMed
rs144459039
CA89907294
232 M>V No ClinGen
ESP
TOPMed
gnomAD
rs1171853961
CA355849586
233 N>I No ClinGen
TOPMed
rs1411806588
CA355849601
234 S>C No ClinGen
TOPMed
CA89909837
rs1051120305
238 T>I No ClinGen
Ensembl
rs746832232
CA2748224
242 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA2748225
rs371896958
242 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1199677566
CA355850396
243 F>I No ClinGen
TOPMed
rs748102251
CA2748227
245 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA89909839
rs753190955
248 L>S No ClinGen
Ensembl
CA2748229
rs758711603
250 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA2748230
rs146167852
250 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2748231
rs139875975
251 E>K No ClinGen
ESP
ExAC
CA89909840
rs952657126
255 I>M No ClinGen
Ensembl
rs761091147
CA2748233
257 W>C No ClinGen
ExAC
gnomAD
CA2748234
rs576354653
259 P>S No ClinGen
1000Genomes
ExAC
gnomAD
rs757780443
CA2748236
261 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA89909841
rs757780443
261 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA2748237
rs182664343
263 H>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA89909842
rs879095466
263 H>Y No ClinGen
Ensembl
CA355848353
rs1314188249
265 D>E No ClinGen
TOPMed
gnomAD
CA355848355
rs1403131028
266 I>F No ClinGen
TOPMed
CA2748238
rs749944927
267 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA89909843
rs749944927
267 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA355848385
rs1376302261
269 W>R No ClinGen
TOPMed
rs1321936658
CA355848397
270 Y>C No ClinGen
TOPMed
gnomAD
rs997278239
CA89909972
272 N>H No ClinGen
gnomAD
COSM43058
CA2748257
rs750933745
273 P>L Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA355848420
rs750933745
273 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs765918670
CA2748259
277 F>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 277 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2748261
rs148527071
280 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1186598845
CA355848481
281 Y>* No ClinGen
TOPMed
rs1206800132
CA355848476
281 Y>H No ClinGen
gnomAD
CA2748262
rs780959619
282 K>Q No ClinGen
ExAC
gnomAD
rs752587119
CA2748263
283 T>I No ClinGen
ExAC
gnomAD
rs1270515322
CA355848504
285 R>C No ClinGen
gnomAD
rs192611052
CA2748266
285 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA2748265
rs192611052
285 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs770711814
CA2748267
287 L>V No ClinGen
ExAC
gnomAD
TCGA novel 290 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2748268
rs780126474
290 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA2748269
rs747048020
292 P>S No ClinGen
ExAC
gnomAD
CA89909973
rs980098029
296 L>I No ClinGen
TOPMed
COSM141071
CA2748270
rs768908134
298 P>S upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1353471716
CA355848598
299 Q>R No ClinGen
TOPMed
CA355848604
rs1282723398
300 M>L No ClinGen
TOPMed
CA355848613
rs1305203863
301 P>H No ClinGen
gnomAD
rs776814172
CA2748271
301 P>S No ClinGen
ExAC
rs541483340
CA2748274
307 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs763531128
CA2748275
308 L>I No ClinGen
ExAC
TOPMed
gnomAD
CA355848699
rs1293528570
313 P>L No ClinGen
gnomAD
CA2748278
rs147654981
313 P>S No ClinGen
ESP
ExAC
gnomAD
rs945262217
CA89909974
316 I>M No ClinGen
TOPMed
CA355848752
rs1186121445
321 P>S No ClinGen
gnomAD
rs1445625280
CA355848767
323 S>F No ClinGen
gnomAD
rs1162392277
CA355848780
325 M>I No ClinGen
TOPMed
rs756982737
CA2748302
328 I>T No ClinGen
ExAC
gnomAD
CA2748301
rs753704231
328 I>V No ClinGen
ExAC
gnomAD
rs1415193030
CA355848814
329 I>F No ClinGen
TOPMed
CA2748303
rs765219640
329 I>T No ClinGen
ExAC
gnomAD
CA2748304
rs750360040
330 I>V No ClinGen
ExAC
rs141298571
CA2748305
331 M>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 332 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200351600
CA2748306
333 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA2748310
rs749717895
337 Q>H No ClinGen
ExAC
gnomAD
rs1284232707
CA903968583
343 F>* No ClinGen
TOPMed
rs1271500275
CA355848938
347 K>E No ClinGen
TOPMed
CA2748312
rs774789937
347 K>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2748313
rs746386986
348 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA89910078
rs950997257
348 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA355848948
rs1485375974
349 K>E No ClinGen
gnomAD
rs1198391239
CA355848952
349 K>R No ClinGen
gnomAD
CA355848961
rs1430159840
350 T>I No ClinGen
gnomAD
CA2748316
rs7629263
CA2748315
351 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2748318
rs776137095
352 V>E No ClinGen
ExAC
gnomAD
rs763859098
CA355848969
352 V>L No ClinGen
ExAC
gnomAD
CA2748317
rs763859098
352 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA355849038
rs1383703578
361 D>Y No ClinGen
TOPMed
CA355849071
rs1480448619
365 T>M No ClinGen
TOPMed
gnomAD
CA89910080
rs1039794599
366 M>T No ClinGen
Ensembl
rs1450021505
CA355849086
368 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA2748323
rs766265524
370 H>L No ClinGen
ExAC
gnomAD
CA2748324
rs752864034
371 P>A No ClinGen
ExAC
gnomAD
rs756132824
CA2748325
371 P>L No ClinGen
ExAC
gnomAD
CA355849116
rs757496249
373 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs757496249
CA2748328
373 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA355849135
rs1481462626
375 E>D No ClinGen
gnomAD
rs779438137
CA2748330
375 E>G No ClinGen
ExAC
gnomAD
rs766603901
CA2748332
385 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA355849273
rs1418484317
387 D>Y No ClinGen
gnomAD
rs775836421
CA2748333
388 E>K No ClinGen
ExAC
gnomAD
rs1346806548
CA355849340
391 Y>N No ClinGen
gnomAD
CA89910082
rs933095746
391 Y>S No ClinGen
TOPMed
rs776144488
CA2748336
396 A>G No ClinGen
ExAC
gnomAD
rs1004769428
CA89910083
396 A>P No ClinGen
Ensembl
CA2748337
rs188879099
397 T>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1335673967
CA355849450
400 G>C No ClinGen
TOPMed
rs368118201
CA2748339
402 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2748338
rs769388229
402 R>W No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with P15907

No regional properties for P15907

Type Name Position InterPro Accession
No domain, repeats, and functional sites for P15907

Functions

Description
EC Number 2.4.3.1 Sialyltransferases
Subcellular Localization
  • Golgi apparatus, Golgi stack membrane ; Single-pass type II membrane protein
  • Secreted
  • Membrane-bound form in trans cisternae of Golgi
  • Secreted into the body fluid
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi cisterna membrane The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.
Golgi medial cisterna The middle Golgi cisterna (or cisternae).
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
Golgi trans cisterna The Golgi cisterna farthest from the endoplasmic reticulum; the final processing compartment through which proteins pass before exiting the Golgi apparatus; the compartment in which N-linked protein glycosylation is completed.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

3 GO annotations of molecular function

Name Definition
beta-galactoside alpha-2,6-sialyltransferase activity Catalysis of the reaction: CMP-N-acetylneuraminate + beta-D-galactosyl-(1->4)-acetyl-beta-D-glucosamine = CMP + alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine.
protein homodimerization activity Binding to an identical protein to form a homodimer.
sialyltransferase activity Catalysis of the transfer of sialic acid to an acceptor molecule, typically the terminal portions of the sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins.

12 GO annotations of biological process

Name Definition
humoral immune response An immune response mediated through a body fluid.
N-acetylneuraminate metabolic process The chemical reactions and pathways involving N-acetylneuraminate, the anion of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid.
negative regulation of chemotaxis Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
negative regulation of macrophage apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
O-glycan processing The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.
positive regulation of mononuclear cell proliferation Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation.
protein N-linked glycosylation via asparagine The glycosylation of protein via the N4 atom of peptidyl-asparagine forming N4-glycosyl-L-asparagine; the most common form is N-acetylglucosaminyl asparagine; N-acetylgalactosaminyl asparagine and N4 glucosyl asparagine also occur. This modification typically occurs in extracellular peptides with an N-X-(ST) motif. Partial modification has been observed to occur with cysteine, rather than serine or threonine, in the third position; secondary structure features are important, and proline in the second or fourth positions inhibits modification.
protein sialylation A protein modification process that results in the addition of a sialic acid unit to the end of an oligosaccharide chain in a glycoprotein.
regulation of substrate adhesion-dependent cell spreading Any process that modulates the frequency, rate or extent of substrate adhesion-dependent cell spreading.
response to ethanol Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
sialylation The covalent attachment of sialic acid to a substrate molecule.
viral protein processing Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q92184 ST6GALNAC2 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Gallus gallus (Chicken) PR
Q701R0 ST6GAL2 Beta-galactoside alpha-2,6-sialyltransferase 2 Gallus gallus (Chicken) PR
Q92182 ST6GAL1 Beta-galactoside alpha-2,6-sialyltransferase 1 Gallus gallus (Chicken) PR
Q9UJ37 ST6GALNAC2 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Homo sapiens (Human) PR
Q9BVH7 ST6GALNAC5 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Homo sapiens (Human) PR
Q96JF0 ST6GAL2 Beta-galactoside alpha-2,6-sialyltransferase 2 Homo sapiens (Human) PR
Q9QYJ1 St6galnac5 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Mus musculus (Mouse) PR
P70277 St6galnac2 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Mus musculus (Mouse) PR
Q64685 St6gal1 Beta-galactoside alpha-2,6-sialyltransferase 1 Mus musculus (Mouse) PR
P13721 St6gal1 Beta-galactoside alpha-2,6-sialyltransferase 1 Rattus norvegicus (Rat) PR
Q9SGD2 GALT29A Beta-1,6-galactosyltransferase GALT29A Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MIHTNLKKKF SCCVLVFLLF AVICVWKEKK KGSYYDSFKL QTKEFQVLKS LGKLAMGSDS
70 80 90 100 110 120
QSVSSSSTQD PHRGRQTLGS LRGLAKAKPE ASFQVWNKDS SSKNLIPRLQ KIWKNYLSMN
130 140 150 160 170 180
KYKVSYKGPG PGIKFSAEAL RCHLRDHVNV SMVEVTDFPF NTSEWEGYLP KESIRTKAGP
190 200 210 220 230 240
WGRCAVVSSA GSLKSSQLGR EIDDHDAVLR FNGAPTANFQ QDVGTKTTIR LMNSQLVTTE
250 260 270 280 290 300
KRFLKDSLYN EGILIVWDPS VYHSDIPKWY QNPDYNFFNN YKTYRKLHPN QPFYILKPQM
310 320 330 340 350 360
PWELWDILQE ISPEEIQPNP PSSGMLGIII MMTLCDQVDI YEFLPSKRKT DVCYYYQKFF
370 380 390 400
DSACTMGAYH PLLYEKNLVK HLNQGTDEDI YLLGKATLPG FRTIHC